Grifols operates in three segments, including Bioscience, Hospital, and Diagnostic, with Bioscience contributing 77% of sales in 2021. The company collects plasma and manufactures and sells plasma-derived products globally. Grifols has smaller segments, including diagnostics, hospital supplies, and biosupplies. The company is focused on treating conditions across a broad range of therapeutic areas and has been recognized by Forbes as one of the "Best Employers for Women," "America's Best Large Employers," and one of the "75 Best Companies to Work for" in Spain.